Medicina
Departamento
University Hospital Aachen
Aachen, AlemaniaPublicaciones en colaboración con investigadores/as de University Hospital Aachen (35)
2024
-
Sodium-glucose cotransporter 2 inhibition in primary and secondary glomerulonephritis
Nephrology Dialysis Transplantation, Vol. 39, Núm. 2, pp. 328-340
2023
-
A meta-analysis of GFR slope as a surrogate endpoint for kidney failure
Nature Medicine, Vol. 29, Núm. 7, pp. 1867-1876
-
Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4
Haematologica, Vol. 108, Núm. 1, pp. 34-41
-
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
The Lancet, Vol. 402, Núm. 10417, pp. 2077-2090
-
Lack of Cyclin E1 in hepatocytes aggravates ethanol-induced liver injury and hepatic steatosis in experimental murine model of acute and chronic alcohol-associated liver disease
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1869, Núm. 4
-
Long-term outcomes of patients with normal fractional flow reserve and thin-cap fibroatheroma
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 18, Núm. 13, pp. e1099-e1107
-
Morphological characteristics of lesions with thin cap fibroatheroma-a substudy from the COMBINE (OCT-FFR) trial
European heart journal. Cardiovascular Imaging, Vol. 24, Núm. 5, pp. 687-693
-
Neuroblastoma RAS viral oncogene homolog (N-RAS) deficiency aggravates liver injury and fibrosis
Cell death & disease, Vol. 14, Núm. 8, pp. 514
-
Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET)
Gut, Vol. 72, Núm. 8, pp. 1581-1591
2022
-
A Shortcut from Metabolic-Associated Fatty Liver Disease (MAFLD) to Hepatocellular Carcinoma (HCC): c-MYC a Promising Target for Preventative Strategies and Individualized Therapy
Cancers, Vol. 14, Núm. 1
-
Activation of the unfolded protein response (Upr) is associated with cholangiocellular injury, fibrosis and carcinogenesis in an experimental model of fibropolycystic liver disease
Cancers, Vol. 14, Núm. 1
-
Genetic and pharmacological inhibition of XBP1 protects against APAP hepatotoxicity through the activation of autophagy
Cell death & disease, Vol. 13, Núm. 2, pp. 143
-
Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH)
Gastroenterologia y Hepatologia, Vol. 45, Núm. 9, pp. 724-734
-
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer
Annals of Oncology, Vol. 33, Núm. 12, pp. 1250-1268
-
Thin-Cap Fibroatheroma Rather Than Any Lipid Plaques Increases the Risk of Cardiovascular Events in Diabetic Patients: Insights from the COMBINE OCT-FFR Trial
Circulation: Cardiovascular Interventions, Vol. 15, Núm. 5, pp. E011728
2021
-
Abnormal liver function test in patients infected with coronavirus (Sars-cov-2): A retrospective single-center study from spain
Journal of Clinical Medicine, Vol. 10, Núm. 5, pp. 1-18
-
An Experimental DUAL Model of Advanced Liver Damage
Hepatology Communications, Vol. 5, Núm. 6, pp. 1051-1068
-
Fat: Quality, or quantity? what matters most for the progression of metabolic associated fatty liver disease (mafld)
Biomedicines, Vol. 9, Núm. 10
-
Incidence and predictive biomarkers of Clostridioides difficile infection in hospitalized patients receiving broad-spectrum antibiotics
Nature Communications, Vol. 12, Núm. 1
-
Microbiota-based markers predictive of development of Clostridioides difficile infection
Nature Communications, Vol. 12, Núm. 1